Last updated 2026-07-20
- Raised Pre-Seed round led by NGT HealthCare II, Jan 2023
Total raised
—
Last: Undisclosed Round 2023-02
Stage
Pre-Seed
Founded
2023
Headcount
6
HQ
Nazareth, Israel
Sector
Health Tech & Life Sciences
About
UB Therapeutics is a biotechnology company focused on developing novel cyclic peptide therapies for the treatment of multiple myeloma. The company's lead candidate, UB4a-GRR, targets multiple myeloma by inhibiting proteasome activity, a critical pathway in cancer cell survival. Their approach aims to address drug resistance in multiple myeloma patients.
Funding history · 1 round · — total
2023-01
Pre-Seed
Undisclosed
★ NGT HealthCare II★ Israel Innovation Authority
Headcount over time
From 1 (2023-03) to 3 (2026-03) · +2 (+200%) · 4 points · source: Finder history + radar grounding
Q&A
- What is UB Therapeutics' primary focus?
- UB Therapeutics is a biotechnology company developing a novel therapy for the treatment of multiple myeloma.
- What type of compound is UB Therapeutics developing?
- The company's compound is a cyclic peptide with potential anticancer therapeutic activity, designed to block deubiquitinases and the proteasome.
- When was UB Therapeutics founded?
- UB Therapeutics was founded in January 2023.
- How many employees does UB Therapeutics currently have?
- UB Therapeutics has 1-10 employees.
- What is the total amount of funding UB Therapeutics has raised to date?
- UB Therapeutics has raised a total of $415,415 USD.
- When was UB Therapeutics' last funding round and who were the investors?
- In February 2023, UB Therapeutics secured funding from NGT HealthCare II and Israel Innovation Authority.
- What is UB Therapeutics' current funding stage?
- UB Therapeutics is currently in the Pre-Seed funding stage.
- Who is the founder of UB Therapeutics?
- Ashraf Brik is the founder of UB Therapeutics.
Team · 2
Dima Ghannam-Shahbari
Founder · CEO & Co-Founder
Ashraf Brik
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business model
B2B2C
Tags
cancer-therapyhealthcarebiotechnologypharmaceuticalscancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | ngt-healthcare2.com/ub-therapeutics/ |
|---|---|
| linkedin.com/company/90868159 |
Identifiers & details
| Legal name | UB THERAPUTICS LTD |
|---|---|
| Founded | 2023-1 |
| Employees (exact) | 6 |
Radar intelligence
Web history (Wayback)
| Domain | ngt-healthcare2.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516743184 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2023-01-11 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | ואדי אל-חאג' 13 נצרת |